Skip to main content
. Author manuscript; available in PMC: 2020 Dec 12.
Published in final edited form as: Antivir Ther. 2010;15(7):935–950. doi: 10.3851/IMP1667

Figure 11.

Figure 11.

Acyclic nucleoside phosphonatesa

aFrom reference [69]. bAt the position indicated with an asterisk. cEffective concentration of compound required to reduce HCV replication by 50% (EC50) dConcentration of inhibitor reducing cell viability by 50% (CC50).